欧洲肝脏研究学会-欧洲糖尿病研究学会-欧洲肥胖症研究学会非酒精性脂肪性肝病管理临床实践指南 - Suppr

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.

机构信息

European Association for the Study of the Liver (EASL), The EASL Building – Home of European Hepatology, 7 rue Daubin, CH 1203 Geneva, Switzerland.

出版信息

J Hepatol. 2016 Jun;64(6):1388-402. doi: 10.1016/j.jhep.2015.11.004. Epub 2016 Apr 7.

DOI:10.1016/j.jhep.2015.11.004

PMID:27062661

Abstract

摘要

相似文献

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.

J Hepatol. 2016 Jun;64(6):1388-402. doi: 10.1016/j.jhep.2015.11.004. Epub 2016 Apr 7.

EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?

Diabetologia. 2017 Jul;60(7):1218-1222. doi: 10.1007/s00125-017-4264-9. Epub 2017 Mar 28.

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?

Diabetologia. 2016 Jun;59(6):1141-4. doi: 10.1007/s00125-016-3910-y. Epub 2016 Apr 7.

European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes.

Diabet Med. 2018 Mar;35(3):368-375. doi: 10.1111/dme.13565. Epub 2018 Jan 10.

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.

Diabetologia. 2016 Jun;59(6):1121-40. doi: 10.1007/s00125-016-3902-y.

Comment to: "EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease".

J Hepatol. 2017 Feb;66(2):465-466. doi: 10.1016/j.jhep.2016.10.036. Epub 2016 Nov 14.

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: disease mongering or call to action?

Diabetologia. 2016 Jun;59(6):1145-7. doi: 10.1007/s00125-016-3930-7. Epub 2016 Apr 7.

Response to: Comment to "EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease".

J Hepatol. 2017 Feb;66(2):466-467. doi: 10.1016/j.jhep.2016.11.002. Epub 2016 Nov 14.

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: guidelines, clinical reality and health economic aspects.

Diabetologia. 2016 Jun;59(6):1148-9. doi: 10.1007/s00125-016-3941-4. Epub 2016 Apr 7.

[Non-alcoholic fatty liver disease - a summary and update based on the EASL-EASD-EASO Clinical Practice Guidelines of 2016].

Orv Hetil. 2018 Nov;159(45):1815-1830. doi: 10.1556/650.2018.31231.

引用本文的文献

() rs738409 Variant and Non-Alcoholic Fatty Liver Disease Risk in Vietnamese Working-Age Adults: A Case-Control Study with Metabolic Insights.

Clin Exp Gastroenterol. 2025 Aug 29;18:191-204. doi: 10.2147/CEG.S532528. eCollection 2025.

Global, regional, and national burden of NASH related liver cancer in adults aged 45 and above: an analysis from the GBD 2021 and forecast to 2050.

Front Nutr. 2025 Aug 19;12:1651357. doi: 10.3389/fnut.2025.1651357. eCollection 2025.

Metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma: Challenges in clinical practice.

Clin Exp Hepatol. 2025 Jun;11(2):105-112. doi: 10.5114/ceh.2025.151618. Epub 2025 Jun 9.

Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver disease.

World J Hepatol. 2025 Aug 27;17(8):108182. doi: 10.4254/wjh.v17.i8.108182.

StackNAFLD: An Accurate Stacking Ensemble Learning Targeting NAFLD Treatment.

ACS Omega. 2025 Aug 15;10(33):37096-37114. doi: 10.1021/acsomega.5c01473. eCollection 2025 Aug 26.

Bile acids for metabolic dysfunction-associated steatotic liver disease in adults.

Cochrane Database Syst Rev. 2025 Sep 2;9(9):CD014850. doi: 10.1002/14651858.CD014850.

Metabolic Dysfunction-Associated Steatotic Liver Disease: A Silent Driver of Cardiovascular Risk and a New Target for Intervention.

Int J Mol Sci. 2025 Aug 21;26(16):8081. doi: 10.3390/ijms26168081.

Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials.

BMC Med. 2025 Aug 27;23(1):502. doi: 10.1186/s12916-025-04320-7.

Consistency and reliability of ultrasound-derived fat fraction in hepatic steatosis assessment: influence of posture and breathing variations.

BMC Med Imaging. 2025 Aug 20;25(1):340. doi: 10.1186/s12880-025-01883-y.

Long-term exposure to air pollution and liver fibrosis in the elderly with MASLD.

Sci Rep. 2025 Aug 15;15(1):29969. doi: 10.1038/s41598-025-15114-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献